<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Pericardial effusion: Approach to diagnosis</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Pericardial effusion: Approach to diagnosis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Pericardial effusion: Approach to diagnosis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Brian D Hoit, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Martin M LeWinter, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Daniel J Sexton, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Susan B Yeon, MD, JD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Nov 10, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1316214658"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The pericardium is a fibroelastic sac surrounding the heart that contains a thin layer of fluid. A pericardial effusion is considered to be present when accumulated fluid within the sac exceeds the small physiologic amount (15 to 50 mL). An approach to pericardial effusion, including identification and management, is presented here.</p><p>Related issues are discussed separately:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/4957.html" rel="external">"Etiology of pericardial disease"</a> and  <a class="medical medical_review" href="/z/d/html/4940.html" rel="external">"Acute pericarditis: Clinical presentation and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/4954.html" rel="external">"Pericardial disease associated with cancer: Clinical presentation and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/2128.html" rel="external">"Purulent pericarditis"</a> and  <a class="medical medical_review" href="/z/d/html/8002.html" rel="external">"Tuberculous pericarditis"</a> and  <a class="medical medical_review" href="/z/d/html/4915.html" rel="external">"Post-cardiac injury syndromes"</a> and  <a class="medical medical_review" href="/z/d/html/4937.html" rel="external">"Pericardial complications of myocardial infarction"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/4934.html" rel="external">"Management of pericardial effusion and acute pericarditis during pregnancy"</a> and  <a class="medical medical_review" href="/z/d/html/141940.html" rel="external">"Pericardial disease associated with cancer: Management"</a>.)</p><p></p><p class="headingAnchor" id="H1931771240"><span class="h1">WHEN TO SUSPECT PERICARDIAL EFFUSION</span><span class="headingEndMark"> — </span>Pericardial effusion should be suspected in the following clinical settings, particularly in patients with any of the disorders known to involve the pericardium  (<a class="graphic graphic_table graphicRef67851" href="/z/d/graphic/67851.html" rel="external">table 1</a>). (See  <a class="medical medical_review" href="/z/d/html/4957.html" rel="external">"Etiology of pericardial disease", section on 'Pericardial effusion'</a>.)</p><p class="headingAnchor" id="H1161424934"><span class="h2">Urgent conditions</span><span class="headingEndMark"> — </span>Diagnosis and management of pericardial effusion is most urgent for patients with cardiac tamponade. Purulent pericarditis also requires urgent identification and treatment.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cardiac tamponade</strong> – Cardiac tamponade is caused by pericardial fluid accumulating under pressure, impairing cardiac filling and reducing stroke volume. Tamponade is suspected based upon the patient's history (which may include a cause of pericardial disease or effusion  (<a class="graphic graphic_table graphicRef67851" href="/z/d/graphic/67851.html" rel="external">table 1</a> and <a class="graphic graphic_table graphicRef78847" href="/z/d/graphic/78847.html" rel="external">table 2</a>)), symptoms (eg, fatigue, dyspnea, syncope, presyncope), and signs. Nearly all patients with cardiac tamponade have one or more of the following physical findings (see  <a class="medical medical_review" href="/z/d/html/4921.html" rel="external">"Cardiac tamponade", section on 'Clinical presentation'</a>):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Sinus tachycardia </strong>– This nonspecific sign is seen in nearly all patients with cardiac tamponade, while hypotension is more variably present. In the setting of cardiac tamponade, sinus tachycardia is a sign of hemodynamic compromise, which should be urgently treated with pericardial fluid drainage.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Elevated jugular venous pressure</strong> – This finding is seen in nearly all patients with cardiac tamponade. Peripheral edema may also be present. However, patients who are severely hypovolemic may present with low pressure tamponade, which is associated with low jugular venous pressure. (See  <a class="medical medical_review" href="/z/d/html/4921.html" rel="external">"Cardiac tamponade", section on 'Low-pressure cardiac tamponade'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Pulsus paradoxus</strong> – This finding is defined as an abnormally large decrease in systolic blood pressure (&gt;10 mmHg) on inspiration. It is a common finding in moderate to severe cardiac tamponade and is a direct consequence of ventricular interdependence  (<a class="graphic graphic_waveform graphicRef55709" href="/z/d/graphic/55709.html" rel="external">waveform 1</a> and <a class="graphic graphic_waveform graphicRef63439" href="/z/d/graphic/63439.html" rel="external">waveform 2</a> and <a class="graphic graphic_waveform graphicRef70731" href="/z/d/graphic/70731.html" rel="external">waveform 3</a>). (See  <a class="medical medical_review" href="/z/d/html/4936.html" rel="external">"Pulsus paradoxus in pericardial disease"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Hemodynamic deterioration</strong> – Cardiac tamponade is one of the causes of hemodynamic instability and should be suspected, particularly in patients with a condition that may involve the pericardium (eg, ascending aortic dissection). (See  <a class="medical medical_review" href="/z/d/html/8190.html" rel="external">"Clinical features and diagnosis of acute aortic dissection", section on 'Hypotension'</a>.)</p><p></p><p class="bulletIndent1">The diagnosis and management of cardiac tamponade, including urgent pericardial fluid removal, are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/4921.html" rel="external">"Cardiac tamponade"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Purulent pericarditis</strong> – This condition typically presents with high fever and tachycardia, with or without chest pain. A high index of suspicion is required, particularly in patients with a known infection that may seed or spread to the pericardium or prior perforating injury of the pericardium. Urgent diagnosis and management is required, as discussed separately. (See  <a class="medical medical_review" href="/z/d/html/2128.html" rel="external">"Purulent pericarditis"</a>.)</p><p></p><p class="headingAnchor" id="H1119575241"><span class="h2">Other clinical settings</span><span class="headingEndMark"> — </span>An evaluation for pericardial effusion is also indicated in patients with the following findings or conditions:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>All cases of acute pericarditis. (See  <a class="medical medical_review" href="/z/d/html/4940.html" rel="external">"Acute pericarditis: Clinical presentation and diagnosis", section on 'Diagnostic evaluation'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Unexplained low voltage on the electrocardiogram (ECG). (See <a class="local">'ECG findings'</a> below.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Unexplained new radiographic cardiomegaly, particularly when present without pulmonary congestion. (See <a class="local">'Chest radiograph'</a> below.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Presence of isolated left (or left larger than right) pleural effusion [<a href="#rid1">1</a>].</p><p></p><p>Additional clinical presentations that may suggest pericardial effusion are discussed below (see <a class="local">'Clinical presentation'</a> below). Also, a pericardial effusion may be detected as an incidental finding on imaging (eg, echocardiography or computed tomography [CT]) performed to evaluate another condition.</p><p class="headingAnchor" id="H260493805"><span class="h2">Clinical presentation</span><span class="headingEndMark"> — </span>The following clinical findings occur in patients with pericardial effusion with or without cardiac tamponade.</p><p class="headingAnchor" id="H2774116717"><span class="h3">Symptoms and signs</span><span class="headingEndMark"> — </span>Patients with pericardial effusion may experience chest pain or fullness. However, many patients with pericardial effusion without tamponade have no symptoms or signs directly caused by the pericardial effusion, although they may have symptoms related to the underlying cause of pericardial disease (eg, fever in the setting of infectious or immune-mediated pericarditis). Thus, pericardial effusions are often discovered incidentally during evaluation for other cardiopulmonary diseases.</p><p>In the absence of cardiac tamponade, physical signs of pericardial effusion are so insensitive and nonspecific that they are of historic rather than practical interest. As an example, the ability to percuss cardiac dullness beyond the apical point of maximal impulse is consistent with pericardial effusion, but it depends upon the absence of disease of the lower lobe of the left lung or left pleura and the expertise of the examiner. Ewart sign (which includes a triangular area of dullness at the tip of the left scapula along with tubular breath sounds and egophony at the same location) suffers from similar limitations [<a href="#rid2">2</a>].</p><p class="headingAnchor" id="H3142599670"><span class="h3">Initial test findings</span><span class="headingEndMark"> — </span>The presence of a pericardial effusion may be suggested by the ECG or chest radiograph.</p><p class="headingAnchor" id="H4463173"><span class="h4">ECG findings</span><span class="headingEndMark"> — </span>An ECG should be performed in patients with suspected pericardial disease. The most common ECG findings in patients with a pericardial effusion are sinus tachycardia, low QRS voltage, and electrical alternans. If pericarditis is present, the ECG findings typical of that disorder (such as ST elevation and PR depression) are also seen  (<a class="graphic graphic_waveform graphicRef77572" href="/z/d/graphic/77572.html" rel="external">waveform 4</a>). (See  <a class="medical medical_review" href="/z/d/html/4940.html" rel="external">"Acute pericarditis: Clinical presentation and diagnosis", section on 'Electrocardiogram'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sinus tachycardia</strong> – Sinus tachycardia (sinus rhythm with rate &gt;100 beats per minute) is a nonspecific sign that is common in patients with pericardial effusion, particularly those with cardiac tamponade. In a study of ECG findings in 241 patients with moderate or large pericardial effusion, sinus tachycardia was present in 43 of 64 patients (67 percent) with cardiac tamponade and 41 of 160 patients (26 percent) without tamponade [<a href="#rid3">3</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Low QRS voltage</strong> – Low QRS voltage is common in patients with pericardial effusion. Low QRS voltage may be observed in the limb leads and/or precordial leads. Low QRS voltage in the limb leads  (<a class="graphic graphic_waveform graphicRef74856" href="/z/d/graphic/74856.html" rel="external">waveform 5</a>) is present when the amplitudes (nadir to peak) of the QRS complexes in each of the six limb leads is less than 5 mm (0.5 mV). Low voltage in the precordial leads is present when the amplitude in each these leads is less than 10 mm (1 mV).</p><p></p><p class="bulletIndent1">While the frequency of low voltage appears to be higher among patients with cardiac tamponade than among other patients with pericardial effusion, the presence of low voltage is not specific for cardiac tamponade. In the above-cited study of ECG findings in 241 patients with moderate or large pericardial effusion, low voltage in limb and/or precordial leads was present in 66 percent of patients with cardiac tamponade and in 34 percent of patients without cardiac tamponade [<a href="#rid3">3</a>]. Low voltage is more common with moderate or large pericardial effusions than with small effusions (eg, 83 versus 13 percent in one series [<a href="#rid4">4</a>]).</p><p></p><p class="bulletIndent1">The combination of low voltage and sinus tachycardia should raise concern about pericardial effusion with cardiac tamponade. However, the combination of low voltage and sinus tachycardia is not specific to patients with pericardial effusion, as this combination of findings may also be seen in patients in a variety of clinical settings, such as chronic obstructive pulmonary disease, pleural effusion, cardiomyopathy, and prior cardiac surgery  (<a class="graphic graphic_table graphicRef80629" href="/z/d/graphic/80629.html" rel="external">table 3</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Electrical alternans</strong> – Electrical alternans is an ECG finding that is observed in some patients with pericardial effusion, particularly those with cardiac tamponade. Electrical alternans is characterized by beat-to-beat alternating amplitude of the QRS complexes (and more subtly of other waveforms) that reflects swinging of the heart in the pericardial fluid  (<a class="graphic graphic_waveform graphicRef72525" href="/z/d/graphic/72525.html" rel="external">waveform 6</a> and <a class="graphic graphic_movie graphicRef66715" href="/z/d/graphic/66715.html" rel="external">movie 1</a>). The pattern is usually most apparent in one or more of the precordial leads. (See  <a class="medical medical_review" href="/z/d/html/2120.html" rel="external">"ECG tutorial: Miscellaneous diagnoses", section on 'Electrical alternans'</a>.)</p><p></p><p class="bulletIndent1">Electrical alternans  (<a class="graphic graphic_waveform graphicRef72525" href="/z/d/graphic/72525.html" rel="external">waveform 6</a>) with sinus tachycardia is a highly specific sign of pericardial effusion, usually with cardiac tamponade, but is only modestly sensitive. As a result, its absence does not exclude cardiac tamponade. In the above-cited study of ECG findings in 241 patients with moderate or large pericardial effusion, electrical alternans was observed in 35 percent of patients with cardiac tamponade and in only 7 percent of patients without tamponade [<a href="#rid3">3</a>].</p><p></p><p class="bulletIndent1">In contrast, QRS alternans with other tachycardias (eg, paroxysmal supraventricular tachycardias or ventricular tachycardia) is a nonspecific finding resulting from alternation in conduction on a beat-to-beat basis, not from mechanical movement of the heart.</p><p></p><p class="headingAnchor" id="H4463320"><span class="h4">Chest radiograph</span><span class="headingEndMark"> — </span>A chest radiograph performed in patients with suspected pericardial effusion may identify findings (such as pleural effusions, lung disease, hilar masses, or mediastinal widening) related to the cause of pericardial effusion [<a href="#rid5">5</a>].</p><p>However, an enlarged cardiac silhouette on chest radiograph is neither a sensitive nor specific sign of pericardial effusion or cardiac tamponade. The findings on chest radiograph in patients with pericardial effusion are variable, depending on the etiology and size of the pericardial effusion and underlying comorbidities. Small to moderate effusions (less than 200 to 300 mL) are generally not associated with significant findings on the chest radiograph [<a href="#rid5">5</a>], while larger pericardial effusions typically present with an enlarged cardiac silhouette with clear lung fields  (<a class="graphic graphic_diagnosticimage graphicRef57640" href="/z/d/graphic/57640.html" rel="external">image 1</a>).</p><p class="headingAnchor" id="H1296718789"><span class="h4">Cardiac biomarkers</span><span class="headingEndMark"> — </span>Among patients with pericardial effusion, cardiac biomarkers (eg, serum troponin) may be elevated in those in whom the effusion occurs in association with acute myopericarditis or myocardial infarction. Troponin elevations, typically modest, may occur in association with a variety of other acute illnesses. (See  <a class="medical medical_review" href="/z/d/html/1469.html" rel="external">"Elevated cardiac troponin concentration in the absence of an acute coronary syndrome"</a> and  <a class="medical medical_review" href="/z/d/html/4940.html" rel="external">"Acute pericarditis: Clinical presentation and diagnosis", section on 'Cardiac biomarkers'</a> and  <a class="medical medical_review" href="/z/d/html/4930.html" rel="external">"Myopericarditis"</a>.)</p><p class="headingAnchor" id="H1715543455"><span class="h1">DIAGNOSTIC APPROACH</span><span class="headingEndMark"> — </span>Once a pericardial effusion is suspected, the diagnostic approach includes the following three steps:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Identify and assess the pericardial effusion</strong> – A pericardial effusion is generally diagnosed by echocardiography, with additional cardiac imaging performed only in selected cases, as discussed below. (See <a class="local">'Cardiac imaging'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Assessing its hemodynamic impact</strong> – Once it is determined that a pericardial effusion is present, the next step is to determine if cardiac tamponade is present, as this is a cause of hemodynamic instability and requires urgent pericardial drainage. (See <a class="local">'Urgent conditions'</a> above and  <a class="medical medical_review" href="/z/d/html/4921.html" rel="external">"Cardiac tamponade"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnostic evaluation</strong> – After a pericardial effusion has been identified, evaluation is performed to determine its cause. (See <a class="local">'Clinical presentation'</a> above.)</p><p></p><p class="headingAnchor" id="H5"><span class="h1">CARDIAC IMAGING</span><span class="headingEndMark"> — </span>An echocardiogram is the key diagnostic test for pericardial effusion [<a href="#rid5">5</a>]. Additional cardiac imaging with cardiac computed tomography (CT), cardiovascular magnetic resonance (CMR) imaging, and cardiac catheterization is reserved for patients in selected clinical settings, as discussed below.</p><p class="headingAnchor" id="H1616016423"><span class="h2">Effusion types</span><span class="headingEndMark"> — </span>A pericardial effusion may be free-flowing or loculated:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Free-flowing effusion</strong> – (See <a class="local">'Effusion size'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Loculated</strong> – When a pericardial effusion becomes loculated (regional or compartmentalized) it may not be visible in standard echocardiographic views. In some cases, it may be best appreciated in subcostal or transesophageal echocardiographic views, or by cardiac CT or CMR. In other cases (eg, cardiac tamponade early after cardiac surgery), a loculated hematoma may be identified by surgical exploration [<a href="#rid6">6</a>].</p><p></p><p class="headingAnchor" id="H1233428930"><span class="h2">Echocardiography</span></p><p class="headingAnchor" id="H2167274063"><span class="h3">Identifying the effusion</span><span class="headingEndMark"> — </span>Most pericardial effusions are diagnosed on transthoracic echocardiogram (TTE). Two-dimensional (2D) echocardiography is both sensitive and specific for the detection of pericardial effusion and also provides information regarding the hemodynamic significance of the effusion (ie, identification of cardiac tamponade). (See <a class="local">'Hemodynamic effects'</a> below and  <a class="medical medical_review" href="/z/d/html/5299.html" rel="external">"Echocardiographic evaluation of the pericardium"</a>.)</p><p>Pericardial fluid appears on an echocardiogram as an echolucent space between the pericardium and the epicardium. Physiologic pericardial fluid (25 to 50 mL) is generally visible only during ventricular systole. A significant pericardial effusion (exceeding 25 to 50 mL) is identified as an echo-free space throughout the cardiac cycle. (See  <a class="medical medical_review" href="/z/d/html/5299.html" rel="external">"Echocardiographic evaluation of the pericardium", section on 'Normal appearance on echocardiographic imaging'</a> and <a class="local">'Effusion size'</a> below.)</p><p>While M-mode echocardiography can identify an effusion  (<a class="graphic graphic_diagnosticimage graphicRef61898" href="/z/d/graphic/61898.html" rel="external">image 2</a>), 2D echocardiography permits a better estimate of the size of the effusion, its distribution, and its distance from potential pericardiocentesis sites.</p><p class="headingAnchor" id="H654877338"><span class="h3">Effusion size</span><span class="headingEndMark"> — </span>Pericardial effusion size is assessed and monitored in patients with pericardial effusion, although pericardial size alone does not determine its hemodynamic significance. (See  <a class="medical medical_review" href="/z/d/html/143123.html" rel="external">"Pericardial effusion: Approach to management", section on 'General management'</a> and <a class="local">'Hemodynamic effects'</a> below.)</p><p>Although 2D echocardiography cannot precisely quantify pericardial effusion size (which is better quantified by cardiac CT or CMR), a common approach is to grade free-flowing effusions as small, medium, or large as determined by the size of the echo-free space surrounding the heart. The site of fluid accumulation for a free-flowing effusion is positional due to gravity dependence.</p><p class="bulletIndent1"><span class="glyph">●</span>Small effusions (50 to 100 mL) are typically only seen posteriorly and are generally less than 10 mm wide, causing minimal separation between the epicardial (visceral) pericardium and the thicker parietal pericardial sac. A small free-flowing pericardial effusion is typically identified on echocardiography above the right atrium in the apical four-chamber view with the patient in the left lateral decubitus position  (<a class="graphic graphic_diagnosticimage graphicRef82562" href="/z/d/graphic/82562.html" rel="external">image 3</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Moderate effusions (100 to 500 mL) are generally seen along the length of the posterior wall but not anteriorly; the echo-free space is 10 to 20 mm at its greatest width.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Large effusions (&gt;500 mL) are generally seen circumferentially  (<a class="graphic graphic_movie graphicRef76287" href="/z/d/graphic/76287.html" rel="external">movie 2</a> and <a class="graphic graphic_diagnosticimage graphicRef56462" href="/z/d/graphic/56462.html" rel="external">image 4</a> and <a class="graphic graphic_diagnosticimage graphicRef57021" href="/z/d/graphic/57021.html" rel="external">image 5</a>); the echo-free space is greater than 20 mm at its greatest width.</p><p></p><p class="headingAnchor" id="H764656437"><span class="h3">Hemodynamic effects</span><span class="headingEndMark"> — </span>The diagnosis of cardiac tamponade is based largely upon clinical and imaging (primarily echocardiographic) findings, although definitive confirmation of the diagnosis is made by hemodynamic assessment via cardiac catheterization during pericardial fluid drainage. (See  <a class="medical medical_review" href="/z/d/html/4921.html" rel="external">"Cardiac tamponade", section on 'Diagnosis'</a>.)</p><p>With cardiac tamponade, the pericardial effusion is commonly moderate or large  (<a class="graphic graphic_movie graphicRef66715" href="/z/d/graphic/66715.html" rel="external">movie 1</a>), but may be small if the effusion has accumulated rapidly. The speed of pericardial fluid accumulation affects the size of pericardial effusion that causes cardiac tamponade  (<a class="graphic graphic_figure graphicRef75068" href="/z/d/graphic/75068.html" rel="external">figure 1</a>). The normal pericardium can stretch to accommodate increases in pericardial volume, with the amount of stretch related to the period of time over which the pericardial effusion accumulates, as discussed separately. (See  <a class="medical medical_review" href="/z/d/html/4921.html" rel="external">"Cardiac tamponade", section on 'Pathophysiology'</a>.)</p><p>Echocardiographic features of cardiac tamponade include (see  <a class="medical medical_review" href="/z/d/html/4921.html" rel="external">"Cardiac tamponade", section on 'Echocardiogram'</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Collapse of the right atrium at end-diastole and the right ventricle in early diastole  (<a class="graphic graphic_movie graphicRef74765" href="/z/d/graphic/74765.html" rel="external">movie 3</a> and <a class="graphic graphic_movie graphicRef64027" href="/z/d/graphic/64027.html" rel="external">movie 4</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Reciprocal changes in left and right ventricular volumes with respiration, which are important in the pathogenesis of pulsus paradoxus  (<a class="graphic graphic_figure graphicRef75980" href="/z/d/graphic/75980.html" rel="external">figure 2</a>). (See  <a class="medical medical_review" href="/z/d/html/4936.html" rel="external">"Pulsus paradoxus in pericardial disease"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Increased respiratory variation of mitral and tricuspid valve inflow velocities (increase in mitral flow by 30 percent and decrease in tricuspid valve flow by 60 percent on the first beat of expiration).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Dilation (plethora) of the inferior vena cava and less than a 50 percent reduction in its diameter during inspiration, reflecting systemic congestion  (<a class="graphic graphic_diagnosticimage graphicRef58804" href="/z/d/graphic/58804.html" rel="external">image 6</a> and <a class="graphic graphic_diagnosticimage graphicRef79134" href="/z/d/graphic/79134.html" rel="external">image 7</a>).</p><p></p><p>The diagnosis and management of cardiac tamponade are discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/4921.html" rel="external">"Cardiac tamponade"</a>.)</p><p class="headingAnchor" id="H3284519642"><span class="h2">Cardiac CT and CMR</span><span class="headingEndMark"> — </span>Imaging with cardiac CT or CMR is reserved for patients with nondiagnostic echocardiographic evaluation who require further assessment to identify and examine a pericardial effusion (eg, suspected loculated effusion) or to identify other suspected pericardial pathology (eg, constrictive pericarditis or a pericardial mass). (See  <a class="medical medical_review" href="/z/d/html/4938.html" rel="external">"Constrictive pericarditis: Diagnostic evaluation", section on 'Additional testing'</a> and  <a class="medical medical_review" href="/z/d/html/4954.html" rel="external">"Pericardial disease associated with cancer: Clinical presentation and diagnosis", section on 'Further cardiac imaging'</a>.)</p><p>Cardiac CT or CMR is helpful in identifying, characterizing, and quantifying a pericardial effusion and also identifying other pericardial findings such as pericardial thickening and pericardial tethering (which are associated with constrictive pericarditis) [<a href="#rid7">7,8</a>]. In patients who are hemodynamically unstable, cardiac CT is generally preferred to CMR. (See <a class="local">'Differential diagnosis'</a> below and  <a class="medical medical_review" href="/z/d/html/4938.html" rel="external">"Constrictive pericarditis: Diagnostic evaluation", section on 'Additional testing'</a>.)</p><p>In some cases, pericardial effusion may be first detected by CT, especially when CT is used to detect pulmonary embolus, a more common cause of shortness of breath and hypotension.</p><p class="headingAnchor" id="H3835082006"><span class="h1">CARDIAC CATHETERIZATION</span><span class="headingEndMark"> — </span>Hemodynamic assessment via cardiac catheterization is generally reserved for patients (usually with suspected cardiac tamponade) undergoing pericardial fluid drainage. When feasible, the diagnosis of cardiac tamponade is confirmed by identifying typical hemodynamic findings prior to pericardial fluid removal and resolution of hemodynamic abnormalities after drainage. (See  <a class="medical medical_review" href="/z/d/html/4921.html" rel="external">"Cardiac tamponade", section on 'Cardiac catheterization'</a>.)</p><p class="headingAnchor" id="H3927745760"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>The differential diagnosis of pericardial effusion suspected on echocardiography includes epicardial fat (commonly visualized anterior to the right ventricular free wall and in the interventricular and atrioventricular grooves) and pleural effusion. These entities can usually be distinguished from pericardial effusion by careful review of the echocardiogram. Epicardial fat may be identified by the presence of faint linear striations within it. A key landmark for posterior pericardial effusion is that it tracks anterior to the descending aorta. If echocardiographic findings are nondiagnostic, cardiac CT or CMR can distinguish these entities. (See  <a class="medical medical_review" href="/z/d/html/5299.html" rel="external">"Echocardiographic evaluation of the pericardium", section on 'Normal anatomy'</a> and  <a class="medical medical_review" href="/z/d/html/5299.html" rel="external">"Echocardiographic evaluation of the pericardium", section on 'Differentiating between pleural and pericardial effusions'</a>.)</p><p class="headingAnchor" id="H3644369433"><span class="h1">IDENTIFYING THE ETIOLOGY</span><span class="headingEndMark"> — </span>The cause of the effusion is investigated by clinical evaluation (history, physical examination, blood tests) and in some cases by evaluation of pericardial fluid with or without pathologic examination of the pericardium  (<a class="graphic graphic_algorithm graphicRef143187" href="/z/d/graphic/143187.html" rel="external">algorithm 1</a>).</p><p>The cause of a pericardial effusion may be apparent or suspected based upon the clinical setting in which it occurs. Examples include suspected cardiac perforation complicating an invasive procedure, breast or lung cancer, a recent myocardial infarction, severe hypothyroidism, or end-stage kidney disease. (See  <a class="medical medical_review" href="/z/d/html/980.html" rel="external">"Invasive diagnostic cardiac electrophysiology studies", section on 'Complications of invasive cardiac electrophysiology studies'</a> and  <a class="medical medical_review" href="/z/d/html/4954.html" rel="external">"Pericardial disease associated with cancer: Clinical presentation and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/4915.html" rel="external">"Post-cardiac injury syndromes"</a> and  <a class="medical medical_review" href="/z/d/html/7172.html" rel="external">"Overview of the management of chronic kidney disease in adults", section on 'Pericarditis'</a> and  <a class="medical medical_review" href="/z/d/html/7846.html" rel="external">"Clinical manifestations of hypothyroidism", section on 'Cardiovascular system'</a> and  <a class="medical medical_review" href="/z/d/html/7846.html" rel="external">"Clinical manifestations of hypothyroidism"</a>.)</p><p>When the cause of pericardial effusion is not apparent, evaluation starts with a clinical assessment but may require sampling of the pericardial effusion and/or the pericardial tissue for laboratory analysis. The frequency of different causes of pericardial effusion varies in published reports, depending in part upon the patient population (location and clinical features), as well as the aggressiveness with which an underlying diagnosis was sought  (<a class="graphic graphic_table graphicRef78847" href="/z/d/graphic/78847.html" rel="external">table 2</a>) [<a href="#rid9">9-12</a>]. (See  <a class="medical medical_review" href="/z/d/html/4957.html" rel="external">"Etiology of pericardial disease"</a>.)</p><p>In many cases, the specific etiology of a pericardial effusion cannot be established even when fluid and/or pericardial tissue is analyzed. The likelihood of establishing a specific cause appears to be greater with larger effusions. In series of patients with acute pericarditis (including those with small or undetectable effusions), the underlying diagnosis was established in only approximately 15 to 20 percent [<a href="#rid13">13,14</a>]. In contrast, studies confined to moderate to large pericardial effusions have revealed diagnoses in up to 90 percent of cases when very aggressive diagnostic approaches are taken [<a href="#rid10">10</a>]. Such aggressive approaches are often not warranted in clinical practice, however, given the benign natural history of many of these effusions. (See  <a class="medical medical_review" href="/z/d/html/4940.html" rel="external">"Acute pericarditis: Clinical presentation and diagnosis", section on 'Establishing a definite etiology'</a>.)</p><p class="headingAnchor" id="H1107470359"><span class="h2">Causes</span><span class="headingEndMark"> — </span>Pericardial effusion can develop in patients with virtually any condition that affects the pericardium, including acute pericarditis and a variety of systemic disorders. The development of a pericardial effusion may have important implications for prognosis (as in patients with intrathoracic neoplasm), diagnosis (as in myopericarditis or acute pericarditis), or both (as in dissection of the ascending aorta).</p><p>Pericardial effusions can occur as a component of almost any pericardial disorder  (<a class="graphic graphic_table graphicRef67851" href="/z/d/graphic/67851.html" rel="external">table 1</a>), but the majority result from one of the following conditions (see  <a class="medical medical_review" href="/z/d/html/4957.html" rel="external">"Etiology of pericardial disease"</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Acute pericarditis (viral, bacterial, tuberculous, or idiopathic in origin)</p><p class="bulletIndent1"><span class="glyph">●</span>Autoimmune disease</p><p class="bulletIndent1"><span class="glyph">●</span>Post-myocardial infarction or cardiac surgery</p><p class="bulletIndent1"><span class="glyph">●</span>Sharp or blunt chest trauma, including a cardiac diagnostic or interventional procedure</p><p class="bulletIndent1"><span class="glyph">●</span>Malignancy, particularly metastatic spread of noncardiac primary tumors</p><p class="bulletIndent1"><span class="glyph">●</span>Mediastinal radiation</p><p class="bulletIndent1"><span class="glyph">●</span>Renal failure with uremia</p><p class="bulletIndent1"><span class="glyph">●</span>Myxedema</p><p class="bulletIndent1"><span class="glyph">●</span>Aortic dissection extending into the pericardium</p><p class="bulletIndent1"><span class="glyph">●</span>Selected drugs</p><p></p><p>The frequency of the different causes of pericardial effusion varies in published reports, depending primarily upon geography and the patient population  (<a class="graphic graphic_table graphicRef78847" href="/z/d/graphic/78847.html" rel="external">table 2</a>). Patients with hemorrhagic pericardial effusions have a somewhat different distribution of causes, although the overlap with serous effusions is significant. (See  <a class="medical medical_review" href="/z/d/html/4957.html" rel="external">"Etiology of pericardial disease", section on 'Spectrum of clinical presentation'</a>.)</p><p class="headingAnchor" id="H2514249359"><span class="h2">Evaluation</span><span class="headingEndMark"> — </span>Selected clinical information may be helpful for establishing the etiology of a pericardial effusion. This was illustrated in a review of 322 patients with a moderate or large pericardial effusion [<a href="#rid9">9</a>]. In 60 percent of patients, the cause of the effusion was a known medical condition. In the remaining patients, the cause of the effusion was assessed based upon the following features:</p><p class="bulletIndent1"><span class="glyph">●</span>The size of the effusion.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The presence or absence of cardiac tamponade.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Inflammatory signs (defined as two or more of the following features: characteristic chest pain, pericardial friction rub, fever &gt;37°C, and diffuse ST-segment elevation).</p><p></p><p>The presence or absence of these features suggested, but did not confirm, a specific diagnosis [<a href="#rid9">9</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>The presence of inflammatory signs was associated with acute idiopathic pericarditis (likelihood ratio 5.4).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A large effusion without inflammatory signs or cardiac tamponade was associated with chronic idiopathic pericardial effusion (likelihood ratio 20).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cardiac tamponade without inflammatory signs was associated with a malignant effusion (likelihood ratio 2.9).</p><p></p><p class="headingAnchor" id="H1833185843"><span class="h3">Laboratory tests</span><span class="headingEndMark"> — </span>If the initial history and physical examination do not suggest a specific diagnosis, extensive laboratory testing seeking an etiology is unlikely to be helpful. In such cases, we limit routine testing to:</p><p class="bulletIndent1"><span class="glyph">●</span>Complete blood count</p><p class="bulletIndent1"><span class="glyph">●</span>Chemistry profile and renal function</p><p class="bulletIndent1"><span class="glyph">●</span>Thyroid function</p><p class="bulletIndent1"><span class="glyph">●</span>Chest radiography</p><p></p><p>A serum antinuclear antibody (ANA) test should be considered in a young female with an effusion and associated acute pericarditis since, rarely, this can be the initial presentation of systemic lupus erythematosus.</p><p>A careful history directed toward the presence of a coexisting rheumatologic disorder should also be obtained. It is important to keep in mind that a positive ANA is a nonspecific finding. In cases where a rheumatologic diagnosis is being considered in a patient with pericarditis and an effusion, a rheumatology consultation should be sought. (See  <a class="medical medical_review" href="/z/d/html/16578.html" rel="external">"Pericardial involvement in systemic autoimmune diseases"</a>.)</p><p class="headingAnchor" id="H694345059"><span class="h3">Pericardial fluid analysis and biopsy</span><span class="headingEndMark"> — </span>Drainage of a pericardial effusion is often performed for therapeutic benefit (ie, in cardiac tamponade). However, pericardial fluid drainage and analysis should be considered for diagnostic purposes in patients without cardiac tamponade if there is significant uncertainty regarding the diagnosis or if knowledge of a particular diagnosis would change the management of the patient (ie, the presence of metastatic malignancy). In addition, pericardial biopsy can be an important part of the diagnostic approach.</p><p>The invasive nature of pericardiocentesis and pericardial biopsy must be weighed against two factors: a relatively low diagnostic yield from the procedure, and the clinical relevance of a specific diagnosis, as many low-risk patients can be managed empirically without making a specific diagnosis. The yield of diagnostic pericardiocentesis has varied in different series, but in most, a definitive diagnosis has been made following pericardiocentesis in less than 40 percent of cases [<a href="#rid10">10,11,13</a>]. In a more contemporary series of 269 patients who had undergone pericardiocentesis, an etiology was determined in 74 percent of cases; the most common etiologies were idiopathic in 26 percent, malignant in 25 percent, and iatrogenic in 20 percent [<a href="#rid15">15</a>]. When an etiology for the pericardial effusion was confirmed, malignancy, purulent infection, and tuberculosis were the most frequently identified causes.</p><p>We consider pericardial fluid analysis and pericardial biopsy separately since they are frequently helpful, but many patients are successfully managed without either procedure. Our approach is in general agreement with the 2015 European Society of Cardiology guidelines for the diagnosis and management of pericardial disease [<a href="#rid5">5</a>].</p><p>We perform pericardial fluid analysis in the following settings:</p><p class="bulletIndent1"><span class="glyph">●</span>In any patient undergoing therapeutic pericardiocentesis for treatment of cardiac tamponade.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>When there is a clinical suspicion of purulent, tuberculous, or neoplastic pericarditis. (See  <a class="medical medical_review" href="/z/d/html/2128.html" rel="external">"Purulent pericarditis"</a> and  <a class="medical medical_review" href="/z/d/html/8002.html" rel="external">"Tuberculous pericarditis"</a> and  <a class="medical medical_review" href="/z/d/html/4954.html" rel="external">"Pericardial disease associated with cancer: Clinical presentation and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In patients with moderate-to-large pericardial effusions of unknown etiology that do not respond rapidly to antiinflammatory therapy.</p><p></p><p>In patients with chronic pericardial effusions, we do not recommend repeated diagnostic pericardiocentesis due to its low yield.</p><p>The biochemical, immunologic, cytologic, and bacteriologic characteristics of an effusion can be established by laboratory analysis of the pericardial fluid. In some cases this analysis can also determine the etiology of the effusion [<a href="#rid16">16,17</a>]. Among the most helpful diagnostic studies are:</p><p class="bulletIndent1"><span class="glyph">●</span>Gram stain and bacterial and fungal culture.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cytology.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Acid-fast bacillus<em> </em>(AFB) stain and mycobacterial culture along with <a class="drug drug_general" data-topicid="9359" href="/z/d/drug information/9359.html" rel="external">adenosine</a> deaminase, interferon-gamma, or lysozyme (for tuberculous pericarditis) [<a href="#rid18">18</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Polymerase chain reaction (PCR) testing is ordered if a specific organism (eg, <em>Mycobacterium tuberculosis</em>) is suspected.</p><p></p><p>Parameters such as protein, lactate dehydrogenase (LDH), glucose, red cell count, and white cell count are rarely helpful in establishing an etiology; specifically, Light criteria, used for differentiating transudative versus exudative pleural effusions, do not reliably distinguish exudative from transudative pericardial effusions and should not be applied to pericardial fluid analysis [<a href="#rid19">19,20</a>]. However, a PCR test for specific viruses can be ordered when management may be affected by the results, such as identifying cytomegalovirus (CMV) in a transplant patient, although the yield of PCR remains fairly low in many instances [<a href="#rid21">21</a>]. (See  <a class="medical medical_review" href="/z/d/html/4957.html" rel="external">"Etiology of pericardial disease"</a> and  <a class="medical medical_review" href="/z/d/html/8002.html" rel="external">"Tuberculous pericarditis"</a> and  <a class="medical medical_review" href="/z/d/html/8305.html" rel="external">"Approach to the diagnosis of cytomegalovirus infection"</a>.)</p><p>If patient characteristics and local expertise favor pericardial drainage via percutaneous pericardiocentesis, analysis is limited to the pericardial fluid. However, whenever surgical drainage is performed, we also recommend pericardial biopsy. In addition, pericardial biopsy should be performed in any patient in whom there is ongoing diagnostic uncertainty as to the etiology if a specific diagnosis would significantly change the management.</p><p>Pericardioscopy enables endoscopic inspection and targeted biopsy of the parietal and visceral pericardium [<a href="#rid2">2</a>]. This approach has been used in patients with unexplained pericardial effusions or to diagnose recurrent idiopathic effusion [<a href="#rid22">22-25</a>]. When performed in one of the few centers with a special interest and expertise in using this approach, a specific diagnosis was established in 49 to 65 percent of patients, a value higher than generally obtained by pericardial biopsy performed under fluoroscopic guidance [<a href="#rid22">22-24</a>].</p><p class="headingAnchor" id="H2514403692"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/116655.html" rel="external">"Society guideline links: Pericardial disease"</a>.)</p><p class="headingAnchor" id="H23"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/z/d/html/82942.html" rel="external">"Patient education: Cardiac tamponade (The Basics)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (see  <a class="medical medical_patient" href="/z/d/html/3427.html" rel="external">"Patient education: Pericarditis (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H24"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Etiology</strong> – Pericardial effusion can develop in patients with virtually any condition that affects the pericardium  (<a class="graphic graphic_table graphicRef67851" href="/z/d/graphic/67851.html" rel="external">table 1</a>), including acute pericarditis and a variety of systemic disorders. The frequency of different causes of pericardial effusion varies in published reports, depending on factors including geography and patient demographics, as well as the aggressiveness with which an underlying diagnosis is sought  (<a class="graphic graphic_table graphicRef78847" href="/z/d/graphic/78847.html" rel="external">table 2</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical presentation </strong>– The presence of pericardial effusion may be suspected from the history, physical examination, ECG, and chest radiograph. However, in the absence of cardiac tamponade, physical signs are not sensitive or specific for pericardial effusion. (See <a class="local">'Diagnostic approach'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis and evaluation</strong> – Once a pericardial effusion is suspected, the diagnostic approach consists of three steps: confirming the presence of a pericardial effusion (generally by echocardiography), assessing its hemodynamic impact (ie, determining if cardiac tamponade is present), and identifying the cause of the pericardial effusion.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Diagnosis</strong> – The presence of pericardial effusion is usually established with echocardiography. (See <a class="local">'Cardiac imaging'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Assess the hemodynamic impact</strong> – Both clinical and echocardiographic findings can be helpful in assessing the hemodynamic impact of a pericardial effusion. Cardiac tamponade occurs when the intrapericardial pressure from an accumulating pericardial effusion impedes filling of one or both ventricles. (See <a class="local">'Urgent conditions'</a> above.)</p><p></p><p class="bulletIndent2">Patients with cardiac tamponade require urgent pericardial fluid drainage, as discussed separately. (See  <a class="medical medical_review" href="/z/d/html/4921.html" rel="external">"Cardiac tamponade"</a> and  <a class="medical medical_review" href="/z/d/html/143123.html" rel="external">"Pericardial effusion: Approach to management", section on 'Indications for pericardial fluid removal'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Identification of the cause</strong> –<strong> </strong>In some cases, the most likely cause of the pericardial effusion will be clear due to the presence of another illness or systemic disorder known to involve the pericardium. If the cause is not apparent, the routine use of a broad panel of screening laboratory tests is not usually helpful. In such cases, evaluation of the pericardial fluid and pericardium itself may suggest an etiology, particularly if the effusion is large.</p><p></p><p class="bulletIndent2">Patients with suspected purulent pericarditis require urgent diagnosis and management, including pericardial drainage, as discussed separately. (See  <a class="medical medical_review" href="/z/d/html/2128.html" rel="external">"Purulent pericarditis"</a>.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Weiss JM, Spodick DH. Association of left pleural effusion with pericardial disease. N Engl J Med 1983; 308:696.</a></li><li><a class="nounderline abstract_t">Ewart W. Practical Aids in the Diagnosis of Pericardial Effusion, in Connection with the Question as to Surgical Treatment. Br Med J 1896; 1:717.</a></li><li><a class="nounderline abstract_t">Mathur AP, Saini A, Lucas BP, et al. Diagnostic accuracy retrospectively of electrocardiographic findings and cancer history for tamponade in patients determined to have pericardial effusion by transthoracic echocardiogram. Am J Cardiol 2013; 111:1062.</a></li><li><a class="nounderline abstract_t">Kudo Y, Yamasaki F, Doi T, et al. Clinical significance of low voltage in asymptomatic patients with pericardial effusion free of heart disease. Chest 2003; 124:2064.</a></li><li><a class="nounderline abstract_t">Adler Y, Charron P, Imazio M, et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2015; 36:2921.</a></li><li><a class="nounderline abstract_t">Ellenbroek DFJ, van Kessel L, Compagner W, et al. Diagnostic performance of echocardiography to predict cardiac tamponade after cardiac surgery. Eur J Cardiothorac Surg 2022; 62.</a></li><li><a class="nounderline abstract_t">Klein AL, Abbara S, Agler DA, et al. American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr 2013; 26:965.</a></li><li><a class="nounderline abstract_t">Rosmini S, Seraphim A, Knott K, et al. Non-invasive characterization of pleural and pericardial effusions using T1 mapping by magnetic resonance imaging. Eur Heart J Cardiovasc Imaging 2022; 23:1117.</a></li><li><a class="nounderline abstract_t">Sagristà-Sauleda J, Mercé J, Permanyer-Miralda G, Soler-Soler J. Clinical clues to the causes of large pericardial effusions. Am J Med 2000; 109:95.</a></li><li><a class="nounderline abstract_t">Corey GR, Campbell PT, Van Trigt P, et al. Etiology of large pericardial effusions. Am J Med 1993; 95:209.</a></li><li><a class="nounderline abstract_t">Levy PY, Corey R, Berger P, et al. Etiologic diagnosis of 204 pericardial effusions. Medicine (Baltimore) 2003; 82:385.</a></li><li><a class="nounderline abstract_t">Ma W, Liu J, Zeng Y, et al. Causes of moderate to large pericardial effusion requiring pericardiocentesis in 140 Han Chinese patients. Herz 2012; 37:183.</a></li><li><a class="nounderline abstract_t">Permanyer-Miralda G, Sagristá-Sauleda J, Soler-Soler J. Primary acute pericardial disease: a prospective series of 231 consecutive patients. Am J Cardiol 1985; 56:623.</a></li><li><a class="nounderline abstract_t">Zayas R, Anguita M, Torres F, et al. Incidence of specific etiology and role of methods for specific etiologic diagnosis of primary acute pericarditis. Am J Cardiol 1995; 75:378.</a></li><li><a class="nounderline abstract_t">Strobbe A, Adriaenssens T, Bennett J, et al. Etiology and Long-Term Outcome of Patients Undergoing Pericardiocentesis. J Am Heart Assoc 2017; 6.</a></li><li><a class="nounderline abstract_t">Tuon FF, Litvoc MN, Lopes MI. Adenosine deaminase and tuberculous pericarditis--a systematic review with meta-analysis. Acta Trop 2006; 99:67.</a></li><li><a class="nounderline abstract_t">Levy PY, Fournier PE, Charrel R, et al. Molecular analysis of pericardial fluid: a 7-year experience. Eur Heart J 2006; 27:1942.</a></li><li><a class="nounderline abstract_t">Chau E, Sarkarati M, Spellberg B. Adenosine Deaminase Diagnostic Testing in Pericardial Fluid. JAMA 2019; 322:163.</a></li><li><a class="nounderline abstract_t">Ben-Horin S, Bank I, Shinfeld A, et al. Diagnostic value of the biochemical composition of pericardial effusions in patients undergoing pericardiocentesis. Am J Cardiol 2007; 99:1294.</a></li><li><a class="nounderline abstract_t">Imazio M, Biondo A, Ricci D, et al. Contemporary biochemical analysis of normal pericardial fluid. Heart 2020; 106:541.</a></li><li><a class="nounderline abstract_t">Ntsekhe M, Mayosi BM. Tuberculous pericarditis with and without HIV. Heart Fail Rev 2013; 18:367.</a></li><li><a class="nounderline abstract_t">Nugue O, Millaire A, Porte H, et al. Pericardioscopy in the etiologic diagnosis of pericardial effusion in 141 consecutive patients. Circulation 1996; 94:1635.</a></li><li><a class="nounderline abstract_t">Pankuweit S, Wädlich A, Meyer E, et al. Cytokine activation in pericardial fluids in different forms of pericarditis. Herz 2000; 25:748.</a></li><li><a class="nounderline abstract_t">Seferović PM, Ristić AD, Maksimović R, et al. Diagnostic value of pericardial biopsy: improvement with extensive sampling enabled by pericardioscopy. Circulation 2003; 107:978.</a></li><li><a class="nounderline abstract_t">Maisch B, Ristić AD, Pankuweit S. Intrapericardial treatment of autoreactive pericardial effusion with triamcinolone; the way to avoid side effects of systemic corticosteroid therapy. Eur Heart J 2002; 23:1503.</a></li></ol></div><div id="topicVersionRevision">Topic 4941 Version 36.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6828108" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Association of left pleural effusion with pericardial disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20756103" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Practical Aids in the Diagnosis of Pericardial Effusion, in Connection with the Question as to Surgical Treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23351462" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Diagnostic accuracy retrospectively of electrocardiographic findings and cancer history for tamponade in patients determined to have pericardial effusion by transthoracic echocardiogram.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14665480" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Clinical significance of low voltage in asymptomatic patients with pericardial effusion free of heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26320112" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34791128" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Diagnostic performance of echocardiography to predict cardiac tamponade after cardiac surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23998693" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34331054" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Non-invasive characterization of pleural and pericardial effusions using T1 mapping by magnetic resonance imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10967149" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Clinical clues to the causes of large pericardial effusions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8356985" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Etiology of large pericardial effusions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14663288" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Etiologic diagnosis of 204 pericardial effusions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21301790" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Causes of moderate to large pericardial effusion requiring pericardiocentesis in 140 Han Chinese patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4050698" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Primary acute pericardial disease: a prospective series of 231 consecutive patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7856532" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Incidence of specific etiology and role of methods for specific etiologic diagnosis of primary acute pericarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29275375" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Etiology and Long-Term Outcome of Patients Undergoing Pericardiocentesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16950165" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Adenosine deaminase and tuberculous pericarditis--a systematic review with meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16717077" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Molecular analysis of pericardial fluid: a 7-year experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31199430" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Adenosine Deaminase Diagnostic Testing in Pericardial Fluid.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17478160" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Diagnostic value of the biochemical composition of pericardial effusions in patients undergoing pericardiocentesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31422364" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Contemporary biochemical analysis of normal pericardial fluid.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22427006" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Tuberculous pericarditis with and without HIV.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8840855" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Pericardioscopy in the etiologic diagnosis of pericardial effusion in 141 consecutive patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11200123" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Cytokine activation in pericardial fluids in different forms of pericarditis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12600910" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Diagnostic value of pericardial biopsy: improvement with extensive sampling enabled by pericardioscopy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12242070" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Intrapericardial treatment of autoreactive pericardial effusion with triamcinolone; the way to avoid side effects of systemic corticosteroid therapy.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
